Summary
A new peripherally acting respiratory stimulant taloximine is shown in a limited double-blind controlled study to be an effective analeptic agent, though probably no more so than ethamivan, in chronic bronchitic patients in moderate cardio-respiratory failure as a result of acute infective exacerbations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Daly, M., Lightowler, J.E., Pickering, R.W.: Taloximine, a new respiratory stimulant with bronchodilator properties. Brit. J. Pharm.35, 283–294 (1969).
Edwards, G., Leszczynski, S.O.: A double-blind trial of five respiratory stimulants in patients in acute ventilatory failure. Lancet1968 II, 225–229.
Pearson, J.A., Griffin, J.P.: Investigations into the site of action of taloximine: A new respiratory stimulant molecule. Experientia25, 716–717 (1969).
Prime, F.J., Griffin, J.P., Turner, P., Ben-Dyke, R., Pickering, R.W.: Metabolic studies of taloximine and its effects on the respiratory response to carbon dioxide. Pharmacol. Clin.2, 155–160 (1970).
Goodman, L.A., Gilman, A.: 3rd Edition 352. New York: MacMillan 1965: Pharmacological basis of therapeutics.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edwards, G., Griffin, J.P. A comparative study of two respiratory stimulants ethamivan and taloximine. Eur J Clin Pharmacol 3, 18–22 (1970). https://doi.org/10.1007/BF00560286
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00560286